Weight-loss drugs like Ozempic and Wegovy are reshaping healthcare — and potentially the economy.
Dr Zac Turner explains to Sean Aylmer how GLP-1 drugs work, what we’re still learning about their long-term effects, why the next generation matters, and how these medications may go far beyond weight loss.

Market jitters follow Trump speech; new gambling advertising rules; Apple turns 50
12:29

Q+A: The story (and person) behind Telstra's brand transformation
12:54

Afternoon Report | Trump fails to impress
03:50